BTIG Maintains Buy on AtriCure, Raises Price Target to $55
AtriCure, Inc.
AtriCure, Inc. ATRC | 0.00 |
BTIG analyst Marie Thibault maintains AtriCure (NASDAQ:
ATRC) with a Buy and raises the price target from $45 to $55.
BTIG Maintains Buy on AtriCure, Raises Price Target to $55
AtriCure, Inc. ATRC | 0.00 |